Skip to main content
. Author manuscript; available in PMC: 2023 Aug 1.
Published in final edited form as: Int J Radiat Oncol Biol Phys. 2022 May 2;113(5):1054–1062. doi: 10.1016/j.ijrobp.2022.04.035

Table 4.

Details of 9 patients treated with ipsilateral radiation who developed recurrent nodal disease in the contralateral neck

Patient Smoker HPV-associated cancer Staging included PET T-category N-category Size of largest node (cm) Concurrent drug with radiation Time to recurrence (from end of radiation) in contralateral neck Other site(s) of recurrence Status from time of recurrence
1 Never Unknown No 1 0 None 6 mo None Alive, 106 mo
2 Former Yes No 2 2b 3.0 None 5 mo Primary and ipsilateral neck Dead, 65 mo
3 Never Yes Yes 1 1 2.0 None 3 mo None Alive, 90 mo
4 Never Yes Yes 2 2b 1.7 Cetuximab 6 mo None Alive, 96 mo
5 Current Yes Yes 1 2b 3.6 Cetuximab 55 mo Primary Alive, 46 mo
6 Never Yes No 2 1 1.7 None 47 mo None Alive, 45 mo
7 Never Unknown No 1 2b 3.0 Cisplatin 46 mo None Alive, 0 mo
8 Former Yes Yes 2 2b 2.8 Cetuximab 3 mo Primary Dead, 34 mo
9 Never Yes Yes 2 2b 2.1 Cetuximab 13 mo None Alive, 30 mo

Abbreviations: HPV = human papillomavirus; PET = positron emission tomography.